Direct-to-Pharmacy moat Medigi operates a marketplace and branded storefronts that enable direct-to-pharmacy purchasing, signaling opportunities to expand partnerships with pharmacies, hospital systems, oncology centers, and infusion facilities seeking streamlined sourcing and transparent pricing.

Pricing Engine leverage The sophisticated pharmaceutical pricing engine enables tailored offers and transparent pricing, creating a compelling value proposition for manufacturers looking to optimize discounts, eligibility, and direct access to pharmacy networks.

Manufacturer network growth With 80+ manufacturers already on the platform, there is clear expansion potential for additional pharma brands and generic players to accelerate direct-to-pharmacy sales and reduce middlemen, appealing to sales teams targeting new manufacturers.

Focused pharma verticals Medigi serves hospital systems, oncology, infusion centers, specialty, and 503B compounders, indicating sales opportunities to these specialized segments that typically rely on efficient, compliant procurement and direct access to inventory.

Tech-enabled operations Leveraging cloud and fintech tools such as AWS, Stripe, QuickBooks, and HubSpot, Medigi demonstrates a scalable platform, offering chances to upsell integration services, pricing strategy enhancements, and analytics-driven procurement improvements for enterprise buyers.